Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Inhibrx Biosciences, Inc. - Common Stock
(NQ:
INBX
)
79.50
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
58.00 (200)
Ask (Size)
125.60 (200)
Prev. Close
79.50
Today's Range
79.50 - 79.50
52wk Range
10.80 - 94.56
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
Unusual volume stocks in Thursday's session
↗
October 30, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Performance
YTD
+5.9%
+5.9%
1 Month
+10.4%
+10.4%
3 Month
-3.8%
-3.8%
6 Month
+206.8%
+206.8%
1 Year
+536.5%
+536.5%
More News
Read More
The trading volume of these stocks is deviating from the norm in today's session.
↗
October 28, 2025
Via
Chartmill
Why Is INBX Stock Rising Today?
↗
October 24, 2025
Via
Stocktwits
INBX Stock Earnings: Inhibrx Beats EPS for Q1 2024
↗
August 22, 2024
Via
InvestorPlace
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone
↗
October 27, 2025
Via
Benzinga
Topics
Economy
Inhibrx Biosciences Soars Over 90% on Breakthrough Rare Bone Cancer Trial Results
October 24, 2025
Via
MarketMinute
Here are the top movers in Friday's session.
↗
October 24, 2025
Via
Chartmill
Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday?
↗
October 24, 2025
Via
Benzinga
Topics
Economy
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 24, 2025
Via
Benzinga
What's going on in today's session
↗
October 24, 2025
Via
Chartmill
Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October
↗
October 24, 2025
Via
Benzinga
Topics
Stocks
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
October 24, 2025
Via
MarketMinute
Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday
↗
October 24, 2025
Via
Benzinga
Which stocks are gapping on Friday?
↗
October 24, 2025
Via
Chartmill
Get insights into the top gainers and losers of Friday's pre-market session.
↗
October 24, 2025
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 24, 2025
Via
Benzinga
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
October 24, 2025
Via
Benzinga
Why Are Inhibrx Biosciences Shares Soaring 76% After Hours?
↗
October 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 23, 2025
Via
Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
October 23, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 22, 2025
Via
Benzinga
Inhibrx Biosciences Beats Earnings
↗
August 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying
↗
September 03, 2024
Via
Benzinga
Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying
↗
August 27, 2024
Via
Benzinga
Frequently Asked Questions
Is Inhibrx Biosciences, Inc. - Common Stock publicly traded?
Yes, Inhibrx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Inhibrx Biosciences, Inc. - Common Stock trade on?
Inhibrx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibrx Biosciences, Inc. - Common Stock?
The ticker symbol for Inhibrx Biosciences, Inc. - Common Stock is INBX on the Nasdaq Stock Market
What is the current price of Inhibrx Biosciences, Inc. - Common Stock?
The current price of Inhibrx Biosciences, Inc. - Common Stock is 79.50
When was Inhibrx Biosciences, Inc. - Common Stock last traded?
The last trade of Inhibrx Biosciences, Inc. - Common Stock was at 02/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
